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Background: The distribution of drug resistance among clinical isolates of
Escherichia coli and Klebsiella pneumoniae has limited the therapeutic options. The
aim of this study was to report the prevalence of quinolone resistance genes among
E. coli and K. pneumoniae clinical strains isolated from three educational hospitals of
Tehran, Iran. Materials and methods: A total of 100 strains of E. coli from
Labbaﬁnejad and Taleghani Hospitals and 100 strains of K. pneumoniae from Moﬁd
Children and Taleghani Hospitals were collected between January 2013 and May
2014. Antimicrobial susceptibility tests were done by disk diffusion method based on
Clinical and Laboratory Standards Institute guidelines. Detection of qepA, aac(6′)-Ib-cr,
acrA, and acrB genes was done by polymerase chain reaction (PCR). Results: In this
study, fosfomycin and imipenem against E. coli and fosfomycin and tigecycline
against K. pneumoniae had the best effect in antimicrobial susceptibility tests. PCR
assay using speciﬁc primers demonstrated that the prevalence of qepA, aac(6′)-Ib-cr,
acrA, and acrB genes among the 100 E. coli isolates was 0 (0%), 87 (87%), 92 (92%),
and 84 (84%), respectively. The prevalence of qepA, aac(6′)-Ib-cr, acrA, and acrB
genes among the 100 K. pneumoniae isolates was 4 (4%), 85 (85%), 94 (94%), and
87 (87%), respectively. Conclusion: The distribution of qepA, aac(6′)-Ib-cr, acrA,
and acrB resistance determinants in E. coli and K. pneumoniae is a great concern.
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Therefore, infection control and prevention of spread of drug-resistant bacteria need
careful management of medication and identiﬁcation of resistant isolates.
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Introduction
Escherichia coli and Klebsiella pneumoniae are the main gram-negative
opportunistic pathogens in nosocomial infections [1, 2]. Virulent strains of E. coli
mostly can cause urinary tract infections, neonatal meningitis, abdominal cramps,
anddiarrhea [3–5].K.pneumoniae can cause clinical infections including respiratory
tract infection, pneumonia, urinary tract infection, wound infection, and bacteremia
[3]. Resistance to ﬂuoroquinolones in clinical isolates of Enterobacteriaceae family
was ﬁrst studied in a K. pneumoniae strain [6, 7]. Recently, ﬂuoroquinolone
resistance has emerged in clinical strains of E. coli and K. pneumoniae [8, 9].
Mutations in topoisomerase IV and DNA gyrase and overexpression of AcrAB
efﬂux system are the main mechanisms of quinolone resistance in E. coli and
K. pneumoniae isolates [10–12]. Plasmid-mediated quinolone resistance (PMQR)
mechanisms have also been reported: Qnr determinants, namely, QnrA, QnrB,
QnrC, QnrD, and QnrS; QepA and OqxAB efﬂux pumps; and AAC(6′)-Ib-cr
enzyme that acetylates aminoglycosides and ciproﬂoxacin [13]. Efﬂux pumps are
transport proteins involved in the extrusion of toxic substrates from intracellular into
the extracellular environment. AcrABandQepAefﬂux pumps have been reported in
clinical isolates of E. coli and K. pneumoniae. These efﬂux proteins can modify the
permeability of the bacterial membrane by drug extrusion to outside, therefore the
antibiotic resistance occurs. AcrAB and QepA multidrug-resistant efﬂux proteins
belong to the major facilitator superfamily group and confers decreased susceptibil-
ity to quinolone. The aac(6′)-Ib-crgene encodes the ability of quinolones acetylation
such as ciproﬂoxacin and norﬂoxacin. Therefore, aac(6′)-Ib-cr gene can diminish
susceptibility to quinolones in addition to aminoglycosides. The aim of this study
was to report the prevalence of quinolone resistance genes, including qepA, aac(6′)-
Ib-cr, acrA, and acrB genes, among E. coli and K. pneumoniae clinical strains
isolated from three educational hospitals of Tehran, Iran.
Methods
Bacterial isolates
A total of 100 strains of E. coli from Labbaﬁnejad and Taleghani Hospitals and
100 strains of K. pneumoniae from Moﬁd Children and Taleghani Hospitals were
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collected between January 2013 and May 2014. The following conventional bio-
chemical tests were done: motility, indole, methyl red, Voges–Proskauer, ornithine
decarboxylase and lysine decarboxylase, Simmons citrate test, and triple sugar iron.
Antimicrobial susceptibility testing
Antimicrobial susceptibility tests were performed by the Kirby-Bauer disk
diffusion method (Mast Group Ltd., Merseyside, UK) according to Clinical and
Laboratory Standards Institute guidelines [14]. The antimicrobial agents tested
were cefpodoxime (30 μg), ciproﬂoxacin (30 μg), imipenem (10 μg), gentamicin
(10 μg), amikacin (30 μg), ampicillin (10 μg), tigecycline (15 μg), cefotaxime
(30 μg), ceftazidime (30 μg), levoﬂoxacin (5 μg), and fosfomycin (50 μg). E. coli
ATCC25922 was used as quality control strain.
PCR detection and DNA sequencing
The DNA was extracted by GeNet Bio company (Korea, Cat. no. K-3000)
and used as a template for polymerase chain reaction (PCR). The quinolone
Table I. Primer sequence and product size
Primer Sequence (5′-3′) Gene Product size (bp)
QepA-F CTGCAGGTACTGCGTCATG qepA 403
QepA-R CGTGTTGCTGGAGTTCTTC
AcrA-F TCTGATCGACGGTGACATCC acrA 157
AcrA-R TCGAGCAATGATTTCCTGCG
AcrB-F CAATACGGAAGAGTTTGGCA acrB 64
AcrB-R CAGACGAACCTGGGAACC
Aac(6′)-Ib-F TTGCGATGCTCTATGAGTGGCTA aac(6′)-Ib 611
Aac(6′)-Ib-R CTCGAATGCCTGGCGTGTTT
Table II. Temperature and time of PCR assay
Step
Temperature (°C) Time
qepA acrA acrB aac(6′)-Ib qepA acrA acrB aac(6′)-Ib
Initial denaturation 94 94 94 94 5 min 5 min 5 min 5 min
Denaturation 94 94 94 94 45 s 45 s 45 s 45 s
Annealing 51 57 52 55 45 s 45 s 45 s 45 s
Extension 72 72 72 72 45 s 45 s 45 s 45 s
Final extension 72 72 72 72 5 min 5 min 5 min 5 min
Cycle 36 36 36 36
DETECTION OF RESISTANCE GENES IN E. COLI AND K. PNEUMONIAE 65
Acta Microbiologica et Immunologica Hungarica 64, 2017
resistance encoding genes, including qepA, aac(6′)-Ib-cr, acrA, and acrB genes
were ampliﬁed for all E. coli and K. pneumoniae strains by means of PCR using
the primer sets and thermal cycling conditions described in Tables I and II. PCR
products were analyzed by electrophoresis in a 1%–1.5% agarose gel. One of the
PCR products was puriﬁed and direct sequencing was done.
Statistical analysis
Our study was a descriptive study. Analysis of results was done by
MINITAB16 software. P value and conﬁdence intervals were <0.05 and 95%,
respectively.
Results
In all the 100 strains of E. coli recovered, 70 strains were isolated from
Labbaﬁnejad Hospital (70%) and 30 from Taleghani Hospital (30%). A total of 33
strains were isolated from male patients (33%) and 67 from female patients (67%).
In all the 100 strains of K. pneumoniae recovered, 50 strains were isolated from
Moﬁd Children Hospital (50%) and 50 from Taleghani Hospital (50%). A total of
57 strains were isolated from male patients (57%) and 43 from female patients
(43%). In this study, fosfomycin and imipenem against E. coli and fosfomycin and
tigecycline against K. pneumoniae had the best effect in antimicrobial suscepti-
bility tests. Antibiotic susceptibility testing results for clinical isolates of E. coli
Table III. Antibiotic susceptibility testing results
Resistant no. (%) Sensitive no. (%) Intermediate no. (%)
Antibiotic K. pneumoniae E. coli K. pneumoniae E. coli K. pneumoniae E. coli
Gentamicin 43 (43%) 80 (80%) 55 (55%) 10 (10%) 2 (2%) 10 (10%)
Amikacin 34 (34%) 17 (17%) 65 (65%) 83 (3%) 2 (2%) 0 (0%)
Imipenem 24 (24%) 3 (3%) 66 (66%) 91 (91%) 10 (10%) 6 (6%)
Cefotaxime 66 (66%) 84 (84%) 33 (33%) 13 (13%) 2 (2%) 3 (3%)
Levoﬂoxacin 70 (70%) 68 (68%) 20 (20%) 20 (20%) 10 (10%) 12 (12%)
Fosfomycin 10 (10%) 5 (5%) 85 (85%) 90 (90%) 5 (5%) 5 (5%)
Ampicillin 62 (62%) 100 (100%) 17 (17%) 0 (0%) 21 (21%) 0 (0%)
Ciproﬂoxacin 83 (83%) 86 (86%) 14 (14%) 10 (10%) 3 (3%) 4 (4%)
Cefpodoxime 72 (72%) 88 (88%) 26 (26%) 12 (12%) 2 (2%) 0 (0%)
Tigecycline 15 (15%) – 30 (30%) – 55 (55%) –
Ceftazidime 62 (62%) 80 (80%) 33 (33%) 15 (15%) 5 (5%) 5 (5%)
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and K. pneumoniae are shown in Table III. The prevalence of qepA, aac(6′)-Ib-cr,
acrA, and acrB genes among the 100 E. coli isolates was 0 (0%), 87 (87%), 92
(92%), and 84 (84%), respectively. The prevalence of qepA, aac(6′)-Ib-cr, acrA,
and acrB genes among the 100 K. pneumoniae isolates was 4 (4%), 85 (85%), 94
(94%), and 87 (87%), respectively.
Discussion
First, PMQR genes were identiﬁed in Enterobacteriaceae family. Then,
qnr determinants, including qnrA, qnrB, qnrC, qnrD, and qnrS, have been
identiﬁed. Furthermore, AAC(6′)-Ib-cr that acetylates aminoglycosides and
ciproﬂoxacin and qepA, which encodes an efﬂux pump, have been identiﬁed
[15]. In this study, the prevalence of qepA gene among K. pneumoniae isolates
was reported 4 (4%), but this gene was not seen among E. coli isolates. These
results are consistent with the study performed by Chen et al. [16] in China,
where 4.9% of qepA gene was positive. Despite this low prevalence rate, this
plasmid-encoding gene, can be moved between hospitals and health-care centers
increase the resistance rate. The AAC(6′)-Ib-cr causes decreased susceptibility
to quinolones in addition to aminoglycosides. In this study, we showed that 87
(87%) clinical isolates of E. coli and 85 (85%) clinical isolates of K. pneumoniae
carried aac(6′)-Ib-cr gene. This high prevalence rate of resistance is a serious
threat to use both the quinolone and aminoglycoside drugs for treatment
programs in the future. It was demonstrated in this survey that ciproﬂoxacin
and levoﬂoxacin had the most drug resistance against E. coli and K. pneumoniae
isolates. The antibiotic susceptibility testing performed by Ma et al. [17]
conﬁrms our results. Recent studies reported several mechanisms for antimi-
crobial resistance ability among clinical isolates of E. coli and K. pneumoniae.
AcrAB efﬂux pump is one of the main chromosomal mechanisms of resistance
to quinolones in Enterobacteriaceae family [18–21]. This efﬂux protein is one
of the important mechanisms in multidrug-resistant E. coli and K. pneumoniae
isolates. This study showed high prevalence rate of acrA and acrB genes among
E. coli isolates, 92% and 84%, respectively, and in K. pneumoniae isolates, 94%
and 87%, respectively. Since the neighboring countries of Iran have a similar
distribution of quinolone resistance genes studied in this survey, the geographi-
cal location can play a key role in spreading of these genes. Recent studies
showed increase in the quinolone-resistant clinical isolates of E. coli and
K. pneumoniae among hospitalized patients in Iran [22, 23]. Much more
investigations need to simplify the actual incidence rate of quinolones resistance
encoding genes.
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